| NCT04672460 |
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors |
View |
| NCT02628860 |
Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy |
View |
| NCT00486460 |
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer |
View |
| NCT00369460 |
Changes in Muscle Tissue in Patients With Pancreatic Cancer |
View |
| NCT02465060 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
View |
| NCT06134960 |
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor |
View |
| NCT01924260 |
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer |
View |
| NCT06378580 |
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma |
View |
| NCT04379960 |
Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines |
View |
| NCT06735560 |
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN |
View |
| NCT04862260 |
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma |
View |
| NCT00425360 |
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
View |
| NCT01643460 |
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts |
View |
| NCT00305760 |
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer |
View |
| NCT02285660 |
Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition |
View |
| NCT05604560 |
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |
View |
| NCT06435260 |
Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer |
View |
| NCT02345460 |
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study |
View |
| NCT05131776 |
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. |
View |
| NCT02910960 |
Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses |
View |
| NCT00908960 |
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles |
View |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer |
View |
| NCT05031494 |
A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers |
View |
| NCT05535894 |
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer |
View |
| NCT01547260 |
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer |
View |
